Grants and Contributions:
Title:
Development of an autoinjector 'Stroke EpiPen' with PSD95 inhibitory for emergency treatment.
Agreement Number:
984185
Agreement Value:
$735,284.00
Agreement Date:
Nov 1, 2021 - May 31, 2023
Description:
NoNO Inc. has developed and autoinjector compatible PSD95 inhibitor to provide neuroprotection that can be administered by any caregiver at home, enroute to the hospital or immediately upon arrival in the emergency department.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5V 1E7
Reference Number:
172-2021-2022-Q4-984185
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
861256576
Recipient Type:
For-profit organization
Recipient's Legal Name:
NoNO Inc.
Federal Riding Name:
Spadina--Fort York
Federal Riding Number:
35101
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710